Solara Active Pharma Sciences Ltd.
BSE: 541540 | Sector: Health care |
NSE: SOLARA | ISIN Code: INE624Z01016 |
BSE 00:00 | 21 Mar | 361.20 |
-1.95 (-0.54%) |
OPEN
368.10 |
HIGH
368.10 |
LOW
358.00 |
NSE 00:00 | 21 Mar | 361.30 |
-1.80 (-0.50%) |
OPEN
365.15 |
HIGH
367.80 |
LOW
357.95 |
OPEN | 368.10 |
PREVIOUS CLOSE | 363.15 |
VOLUME | 51879 |
52-Week high | 838.35 |
52-Week low | 323.65 |
P/E | |
Mkt Cap.(Rs cr) | 1,300 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Solara Active Pharma Sciences Ltd. (SOLARA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 956.20 | -5.05 | -0.53 | 15585.98 |
Dr Reddy's Labs | 4419.30 | -22.50 | -0.51 | 14405.20 |
Cipla | 862.70 | -4.55 | -0.52 | 13091.79 |
Lupin | 649.00 | 2.80 | 0.43 | 11771.67 |
Aurobindo Pharma | 469.20 | -5.05 | -1.06 | 11287.14 |
Divi's Lab. | 2770.70 | -28.25 | -1.01 | 8879.82 |
Alkem Lab | 3110.05 | 1.40 | 0.05 | 8829.81 |
Glenmark Pharma. | 436.20 | -8.80 | -1.98 | 8141.58 |
Zydus Lifesci. | 477.95 | 2.10 | 0.44 | 7981.90 |
Torrent Pharma. | 1515.10 | -7.00 | -0.46 | 6742.32 |
Apollo Hospitals | 4276.65 | -28.80 | -0.67 | 6098.30 |
Ipca Labs. | 780.10 | -0.75 | -0.10 | 5399.36 |
Alembic Pharma | 493.10 | 13.85 | 2.89 | 5035.41 |
Abbott India | 21261.10 | -42.90 | -0.20 | 4919.27 |
Laurus Labs | 305.25 | 2.85 | 0.94 | 4707.04 |
Gland Pharma | 1231.75 | 67.95 | 5.84 | 4400.71 |
Granules India | 288.30 | 6.45 | 2.29 | 3238.44 |
Glaxosmi. Pharma | 1300.40 | 18.65 | 1.46 | 3217.51 |
Ajanta Pharma | 1206.80 | 23.75 | 2.01 | 3140.64 |
Piramal Pharma | 68.76 | 1.53 | 2.28 | 3094.95 |
Quick Links for Solara Active Pharma Sciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices